Capracid en es it fr

Capracid Brand names, Capracid Analogs

Capracid Brand Names Mixture

  • No information avaliable

Capracid Chemical_Formula


Capracid RX_link

Capracid fda sheet

Capracid FDA

Capracid msds (material safety sheet)

Capracid MSDS

Capracid Synthesis Reference

No information avaliable

Capracid Molecular Weight

131.173 g/mol

Capracid Melting Point

205 oC

Capracid H2O Solubility

5.05E+005 mg/L

Capracid State


Capracid LogP


Capracid Dosage Forms

Solution for injection (containing 250 mg/mL of aminocaproic acid) and tablets (500, 1000mg)

Capracid Indication

For use in the treatment of excessive postoperative bleeding.

Capracid Pharmacology

Aminocaproic acid works as an antifibrinolytic. It is a derivative of the amino acid lysine. The fibrinolysis-inhibitory effects of aminocaproic acid appear to be exerted principally via inhibition of plasminogen activators and to a lesser degree through antiplasmin activity.

Capracid Absorption

Absorbed rapidly following oral administration. In adults, oral absorption appears to be a zero-order process with an absorption rate of 5.2 g/hr. The mean lag time in absorption is 10 minutes. After a single oral dose of 5 g, absorption was complete (F=1).

Capracid side effects and Toxicity

A few cases of acute overdosage with intravenous administration have been reported. The effects have ranged from no reaction to transient hypotension to severe acute renal failure leading to death. The intravenous and oral LD50 were 3.0 and 12.0 g/kg respectively in the mouse and 3.2 and 16.4 g/kg respectively in the rat. An intravenous infusion dose of 2.3 g/kg was lethal in the dog.

Capracid Patient Information

Capracid Organisms Affected

Humans and other mammals